Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Committees and advisory bodies (384)
- (-) Safety monitoring and information (27)
- Scheduling (national classification system) (166)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
400 result(s) found, displaying 76 to 100
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling submissionsFind out about public submissions on scheduling matters referred to Advisory Committees meeting, held in June 2023
-
Meeting statementsCommunique from the meeting of the TGACC
-
Scheduling decisions (final)Public notice of final decision to amend (or not amend) the current Poisons Standard - ACMS #41, ACCS #36, Joint ACMS-ACCS #33
-
Scheduling submissionsFind out about public submissions on interim decisions for scheduling matters referred to Advisory Committees meetings, held in March 2023
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsRead the meeting statement from 10 August 2023 meeting of the Advisory Committee on Medical Devices (ACMD).
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
-
Meeting statementsRead key points of discussion from the meeting 11 of the Medical Devices Consumer Working Group (MDCWG).
-
Scheduling submissionsFind out about public submissions on scheduling matters referred to Advisory Committees meetings, held in March 2022.
-
Scheduling submissionsFind out about public submissions on interim decisions for scheduling matters referred to Advisory Committees meetings, held in March 2022.
-
Scheduling submissionsFind out about public submissions on scheduling matters referred to Advisory Committees meeting, held in March 2023
-
Meeting statementsRead the meeting statement from 8 June 2023 meeting of the Advisory Committee on Medical Devices (ACMD).
-
Corporate reportsMandatory reporting of medical device adverse events by healthcare facilities to the TGA has now commenced, with a period of voluntary reporting in place from March 2025 until 20 March 2026.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsCommunique from the 3rd meeting of the Women's Health Products Working Group (WHPWG), 27 March 2023
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), 13 April 2023.